DIA405.21+2.94 0.73%
SPX5,560.83+32.08 0.58%
IXIC17,461.32+95.19 0.55%

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Benzinga·03/19/2025 12:15:46
Listen to the news

U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Wednesday.

Shares of Absci Corporation (NASDAQ:ABSI) fell sharply in today's pre-market trading after the company reported worse-than-expected fourth-quarter financial results.

Absci reported quarterly losses of 25 cents per share which missed the analyst consensus estimate of 23 cents per share. This is unchanged from the same period last year. The company reported quarterly sales of $665.000 thousand which missed the analyst consensus estimate of $1.778 million.

Absci shares dipped 9.4% to $2.79 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

  • Regencell Bioscience Holdings Limited (NASDAQ:RGC) shares dipped 16.1% to $26.50 in pre-market trading after climbing 70% on Tuesday.
  • Turkcell Iletisim Hizmetleri A.S. (NYSE:TKC) shares fell 14.8% to $6.43 in pre-market trading.
  • HealthEquity, Inc. (NASDAQ:HQY) shares declined 14.7% to $86.68 in pre-market trading after the company reported worse-than-expected quarterly earnings results.
  • Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) shares fell 13% to $17.87 in pre-market trading following weak quarterly sales.
  • Waterdrop Inc. (NYSE:WDH) declined 6.5% to $1.30 in pre-market trading following a 5% fall on Tuesday.
  • Resolute Holdings Management, Inc. (NASDAQ:RHLD) declined 4.3% to $34.53 in pre-market trading after dipping 18% on Tuesday.
  • Target Hospitality Corp. (NASDAQ:TH) fell 3.8% to $5.63 in pre-market trading.
  • Alpha Technology Group Limited (NASDAQ:ATGL) fell 3.2% to $31.47 in pre-market trading after gaining 14% on Tuesday.

Now Read This:

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.